Equities

Celsius Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CELH:BRN

Celsius Holdings Inc

Actions
  • Price (CHF)34.14
  • Today's Change-0.385 / -1.12%
  • Shares traded51.00
  • 1 Year change--
  • Beta0.9192
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.

  • Revenue in USD (TTM)2.13bn
  • Net income in USD25.89m
  • Incorporated2005
  • Employees1.07k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CELH:NAQ since
announced
Transaction
value
Alani Nutrition LLCDeal completed20 Feb 202520 Feb 2025Deal completed71.25%1.89bn
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.